BioSavita

Accelerated Biosimilar Antibodies
 BioSavita is focused on rapidly bringing new biosimilar medicines to patients in partnership with biopharmaceutical companies. We have developed proprietary genetically engineered strains of Saccharomyces cerevisiae yeast and Twin Cassette™ yeast expression platform are available for licensing to biopharma companies and academic laboratories for research and production purposes. We can also produce other companies’ recombinant proteins for them. To date, six of the top twenty biopharma companies have licensed our yeast production platform.